Effects of dapagliflozin on kidney function, cardiovascular events and all-cause mortality according to cause of kidney disease in the DAPA-CKD trial

Citation

Wheeler DC, Stefansson BV, Correa-Rotter R, et al. American Society of Nephrology - Kidney Week 2020 Reimagined, 23 October 2020. Abstract FR-OR58.